Chris Bulman Inc

Position in LLY — ELI LILLY & Co

CIK 2032404 ROSEVILLE, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$352,632

+$88,261 QoQ

Shares Held

294

+19.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.68%

of 13F equity value

Holder Rank

#4,039

of 4,605 holders

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Chris Bulman Inc holds $1,680,788 across 5 Drug Manufacturers - General names. LLY ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,003	$504,034
2	LLY	ELI LILLY & Co This page	294	$352,632
3	JNJ	Johnson & Johnson	1,353	$343,621
4	GILD	Gilead Sciences, Inc.	1,923	$242,951
5	AMGN	Amgen Inc	656	$237,550

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$352,632	294	+19.5%	Shares	Sole	2026-07-22
2025-12-31	$264,371	246	-46.2%	Shares	Sole	2026-01-14
2025-06-30	$356,245	457	-11.8%	Shares	Sole	2025-07-14
2025-03-31	$427,821	518	+50.6%	Shares	Sole	2025-04-15
2024-12-31	$265,568	344	-6.8%	Shares	Sole	2025-02-10
2024-09-30	$326,911	369	+36.2%	Shares	Sole	2024-10-22
2024-06-30	$245,357	271	—	Shares	Sole	2024-08-06
No filing history on record for this holder in this stock.